Nasal spray and kindness training aim to quiet inner critic in BPD

NCT ID NCT07551882

Recruiting now Symptom relief Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether combining a nasal spray (oxytocin) with a 5-week self-compassion training program can reduce symptoms like self-criticism, shame, and emotional instability in people with borderline personality disorder (BPD). About 80 adults with BPD will receive either the real spray or a placebo, alongside the training. The goal is to see if this combination improves well-being and social functioning.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BORDERLINE PERSONALITY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

borderline personality disorder spondylocarpotarsal synostosis syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SELF-COMPASSION TRAINING (SCT) PLUS INTRANASAL OXYTOCIN SELF-COMPASSION TRAINING (SCT) PLUS INTRANASAL PLACEBO

Contacts and locations

Show contact details

Study contacts

Contact
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hospital de la Santa Creu i Sant Pau
RECRUITING

Barcelona, Barcelona, 08041, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.